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Abstract
Background: Specialist nurses may play an important role in helping to improve the experiences
of patients with prostate cancer, however there is concern that the specialist nurse role is under
threat in the UK due to financial pressures in the NHS. This study explored the role and value of
specialist nurses in prostate cancer care via a survey and patient interviews.
Methods: This paper reports findings from two studies. A survey of patients from three hospitals
across the UK (289/481, 60%), investigated whether patients who saw a specialist nurse had
different experiences of information provision and involvement in decision-making, to those who
did not. Qualitative interviews were also carried out with 35 men recently tested or treated for
prostate cancer, recruited from two hospitals in the UK. Interviews explored patients' views on
the role and value of the specialist nurse.
Results: Survey findings indicated that patients who saw a specialist nurse had more positive
experiences of receiving written information about tests and treatment, and about sources of
advice and support, and were more likely to say they made the treatment decision themselves. In
interviews, patients described specialist nurse input in their care in terms of providing information
and support immediately post-diagnosis, as well as being involved in ongoing care. Two key aspects
of the specialist nurse role were seen as unique: their availability to the patient, and their ability to
liaise between the patient and the medical system.
Conclusion: This study indicates the unique role that specialist nurses play in the experience of
patients with prostate cancer, and highlights the importance of maintaining specialist nurse roles in
prostate cancer care.
Background
The care that cancer patients in the UK receive has been
under scrutiny, and patients with prostate cancer have
been found to report less positive experiences of care than
patients with other types of cancer. Patients with prostate
cancer are less likely to have the opportunity to discuss
side effects of treatment, to understand how well their
treatment has gone, or to get information about support
and self help groups, than patients with other types of
cancer [1].
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The role of the specialist nurse in prostate cancer care can
be varied, but is primarily focused on the provision of
information and support to patients [2]. Specialist nurse
involvement may help to improve the experiences of
patients with prostate cancer, and may be associated with
positive outcomes [3-5]. The NICE Improving Outcomes
Guidance on urological cancers emphasised the impor-
tance of specialist nurses in prostate cancer care [6], how-
ever, prostate cancer patients have lower levels of access to
specialist nurses than do patients with other types of can-
cer [1]. Individuals and organizations involved in prostate
cancer care have pointed to the availability of specialist
nurses as a key priority for government action [7].
Set against this, current financial pressures in the NHS are
threatening specialist nurse posts, with specialist nurses
expressing concern that they may face losing their jobs, or
may have to give up some or all of their time in their spe-
cialist role to work as generalist nurses on hospital wards
in order to cover staffing shortages [8-10]. The role of spe-
cialist nurses in dealing with information, advice and
emotional support, may appear to be "less tangible and a
relative 'luxury' when compared with ward-based nurses"
[11], leading to their roles being reviewed when resources
are constrained. However, Richardson [12] has identified
that patients with prostate cancer are more likely to report
unmet needs if they do not see a specialist nurse.
There is a need for further research into the role and value
of specialist nurses in prostate cancer care, to support deci-
sions about the importance of maintaining and increasing
the availability of specialist nurses to patients with pros-
tate cancer.
This paper reports findings from two linked studies car-
ried out as part of a larger study to develop a measure of
patient experience of prostate cancer care [13]. A ques-
tionnaire survey of patients' experiences of prostate cancer
care provided an opportunity to investigate whether
patients who saw a specialist nurse had more positive
experiences of care than those who did not. Qualitative
interviews with patients and carers further explored
patient perceptions of the role and value of the specialist
nurse in prostate cancer care.
Methods
Two methodological approaches were used: a quantitative
patient survey and a qualitative investigation of patients'
experiences.
A questionnaire on experiences of prostate cancer care was
mailed to a sample of 481 patients who had been tested
or treated for prostate cancer during the previous two
years at one of three hospitals in different regions of the
UK. Patients were randomly selected from clinic lists for
several clinics at each hospital, including patients who
were undergoing different types of treatment, and were at
different stages in their care. There were no age restrictions
put on the sample. Clinic staff were asked to check the lists
and exclude any patients who had not been diagnosed, or
who were not aware of their diagnosis.
The questionnaire was developed as part of the larger
study, and was based on themes identified through inter-
views of patients with prostate cancer and health profes-
sionals [13]. The questionnaire included a question about
whether the patient had seen a specialist nurse following
their diagnosis. It also included a number of questions
relating to the provision of information about treatment
options, patient involvement in the treatment decision,
and the provision of information about sources of advice
and support. Univariate analysis (ANOVA) was used to
identify whether patients who saw a specialist nurse had
different experiences of these issues to patients who did
not see a specialist nurse.
In order to further explore the role of the specialist nurse
in prostate cancer care, an analysis of patient interviews
undertaken as part of the larger study [13] was also carried
out. Interviews were with prostate cancer patients from
two hospitals in the East Midlands, UK, recruited using a
quota sampling frame to ensure that patients at different
stages of disease and treatment, and in different age and
ethnicity groups, were included. Patients were identified
from attendees at Urology Clinics and from hospitals'
patient registers. In addition, two cancer charities were
asked to contact patients from ethnic minority groups to
ensure that both South Asians and Afro-Caribbeans were
represented in the sample.
The interviews were semi-structured and aimed to explore
patients' experiences over the course of their care, includ-
ing initial GP visit(s), further testing, diagnosis, treatment,
and ongoing monitoring (where relevant). The interviews
did not specifically aim to explore the role of the specialist
nurse, although the role and value of the specialist nurse
emerged as a theme. Interviews were carried out in
patients' own homes; in some cases, the patient's wife or
partner was present and also participated in the interview.
The interviews were audiotaped and transcribed verbatim,
then transferred into the software package NUD*IST 6,
and analysed using the Framework approach [14]. Analy-
sis was undertaken to specifically explore the role and
value of the specialist nurse in patients' experiences of
prostate cancer care. All quotes used have been ano-
nymised, and a patient identification number is given in
brackets at the end of each quote.BMC Health Services Research 2008, 8:65 http://www.biomedcentral.com/1472-6963/8/65
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Results
Participants
The questionnaire was completed by 289 patients (60%).
Of these, 252 (87.2%) had seen a specialist nurse, and 37
(12.8%) had not. The characteristics of survey responders
are given in Table 1. Patients who did not see a specialist
nurse were more likely to be in the 75+ age group than
patients who did see a specialist nurse (F  = 8.20; p  <
0.001), but did not differ significantly in terms of ethnic-
ity, health status, treatment type, or time since most recent
treatment.
Qualitative interviews were carried out with 35 patients;
in 10 of the interviews the wife/partner was also present.
The characteristics of the patients interviewed are given in
Table 2.
Findings – questionnaire survey
Results from the questionnaire survey were analysed to
explore whether patients who saw a specialist nurse had
different experiences of care to patients who did not see a
specialist nurse. Table 3 shows the odds ratios for ques-
tions on patient experience of care, comparing patients
who did see a specialist nurse with those who did not,
adjusted to take patient age into account. An odds ratio
greater than one indicates that a positive response to the
question was more likely in the first group (who did see a
specialist nurse) than in the second group (who did not
see a specialist nurse).
Patients who saw a specialist nurse were significantly
more likely to say that they were given enough written or
printed information about their test results and treatment
options (Table 3, questions 1, 2, 3, 7 and 8). They were
also more likely to feel that their treatment options were
clearly explained (Table 3, question 4). Patients who saw
a specialist nurse were much more likely to report that
they had been given enough information about sources of
help (Table 3, question 13). There were no significant dif-
ferences in terms of whether side effects of treatment were
clearly discussed, or whether the doctor or nurse discussed
with them why other treatment options were not suitable
(Table 3, questions 5 and 6).
Patients who saw a specialist nurse were more likely to say
that they made the treatment decision themselves (Table
3, question 9), although there was no significant differ-
ence between the groups in the extent to which they felt
involved in the treatment decision. Patients who saw a
specialist nurse were more likely to have been told that
they could discuss the treatment decision again, and could
change their mind about treatment (Table 3, questions 11
and 12).
Findings – qualitative interviews
The analysis of the qualitative interviews explored the role
of the specialist nurse in prostate cancer care, with the aim
of understanding the differences in experiences of patients
who did and did not see a specialist nurse, and the per-
ceived value of the specialist nurse role.
Role of the specialist nurse in patients' experiences of prostate 
cancer care
Most patients first saw the specialist nurse after being
given their diagnosis by a consultant. At this stage patients
often had to contemplate their diagnosis, consider a range
of treatment options, and make a treatment decision.
Here the role of the specialist nurse involved providing
time for the patient to talk about the diagnosis and ask
questions, and providing information about the diagno-
sis, treatment options, and support services.
Table 1: Characteristics of questionnaire survey responders (n = 289)
Saw specialist nurse 
number (%)
Did not see specialist 
nurse number (%)
Total number (%)
Age up to 54 6 (2.4) 0 6 (2.1)
55–64 83 (32.9) 7 (18.9) 90 (31.1)
65–74 121 (48.0) 14 (37.8) 135 (46.7)
75 or over 29 (11.5) 16 (43.2) 45 (15.6)
Ethnicity White 211 (83.7) 35 (94.9) 246 (85.1)
South Asian 5 (2.0) 2 (5.4) 7 (2.4)
African/Caribbean 21 (8.3) 0 21 (7.3)
Other 1 (0.4) 0 1 (0.3)
Stage of disease/
treatment
Newly diagnosed (not yet 
treated)
00 0
Being actively monitored without 
treatment
38 (15.1) 10 (27.0) 48 (16.6)
Had curative treatment (e.g. 
prostatectomy, radiotherapy)
147 (58.3) 14 (37.8) 161 (55.7)
Having hormone therapy 52 (20.6) 11 (29.7) 63 (21.8)BMC Health Services Research 2008, 8:65 http://www.biomedcentral.com/1472-6963/8/65
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[Consultant] said to go with the nurse and she'll
explain everything to me, which she did, and made a
good job of it ... I was with her about 20 minutes, half
an hour...to have things explained and you had the
opportunity to ask questions (38)
She was able to talk about the support services that
were available in the event of having different options
(43)
As well as playing an important role for patients immedi-
ately post-diagnosis, specialist nurses provided ongoing
support for many patients during the course of treatment
and follow-up, through their availability for consultation
either by telephone or in person, and in some cases,
through arranging patient support groups:
I will go back and be checked from time to time and
honestly, my nurse specialist is always there and I will
require that service for some time to come (49)
The oncology nurse does run once a month in one of
the local pubs in the town a sort of a prostate get
together and has done for three or four years probably
(15)
Unique features of the specialist nurse role
Analysis of patient interviews highlighted the unique
nature of the specialist nurse role, and the value of this
role to patients. Two key features of the specialist nurse
role distinguished it from the roles of other health profes-
sionals involved in prostate cancer care. These features
were: the availability of the specialist nurse to the patient,
and the ability of the specialist nurse to liaise between the
medical system and the patient.
The availability of the specialist nurse to the patient
Patients described the availability of the specialist nurse
firstly in terms of the amount of time the specialist nurse
was able to spend with them, and secondly in terms of the
specialist nurse's availability for contact throughout their
care.
Firstly, patients felt that the specialist nurse was able to
spend as much time with them as was needed, and that
their time with the nurse was not constrained. This was in
direct contrast with the consultant, who was seen as hav-
ing a limited consultation time. Having this time to talk
things over was particularly important for patients after
being given their diagnosis. The fact that specialist nurses
were available for as much time as the patient needed was
highly valued.
I had two, possibly, at least two meetings of hour and
a half, two hours ...discussing in detail all the possibil-
ities, all the options, my fears ...She did say herself,
take as long as you want, you know, I haven't booked
you down for a specific period of time and the first few
meetings did take an hour and a half, two hours.
Because I had so much to discuss with her (47)
Patients who did not see a specialist nurse after getting
their diagnosis highlighted the lack of unconstrained time
to talk things over, which had a negative emotional
impact on them.
So there I am ... fairly confirmed I would think at that
stage that I'm going to need cancer treatment, but no-
one really to turn to. That was the thing, that in the
whole experience of this, that was the worst moment.
I needed somebody ...you know, in a ten minute
appointment [consultant]'d really stretched his
appointment time I'm sure to give me the benefit of
his knowledge ... But that's what I felt I needed, some-
one to talk to, talk it through (14)
The timing of the consultation with the specialist nurse
was important: one patient described seeing the specialist
nurse immediately after being given the diagnosis, and
felt that this was too soon as he was still in shock follow-
ing the diagnosis.
Table 2: Characteristics of interviewed patients (n = 35)
Total number (%)
Age up to 54 5 (14.3)
55–70 13 (37.1)
70 or over 17 (48.6)
Ethnicity White 26 (74.3)
South Asian 4 (11.4)
African/Caribbean 5 (14.3)
Stage of disease/treatment Newly diagnosed (not yet treated) 3 (8.6)
Being actively monitored without treatment 7 (20.0)
Had curative treatment (e.g. prostatectomy, radiotherapy) 17 (48.6)
Having hormone therapy 8 (22.9)BMC Health Services Research 2008, 8:65 http://www.biomedcentral.com/1472-6963/8/65
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No you can't absorb it and that's in a way was one little
criticism of [specialist] nurse ... 'you've got prostate
cancer' ... and she carts you off into a tiny little cubicle
of a room ...and I don't know what the hell she said
because ...that was too soon ...I was in a, in a state of
numbness anyway at that point and so I don't really
know what it was she was trying to achieve (19)
In contrast, one patient described how the specialist nurse
had been sensitive to his shock and given him time to
come to terms with the diagnosis.
She said to me 'well whatever you are told today you're
not gonna take it all in' so they gave me a booklet on
prostate cancer and treatments, what is involved and
whatever and I was told to go away and read it, and
then if I'd got any questions or you know things like
that... (54)
A second key aspect of availability that patients valued
was the possibility of contact with the specialist nurse for
advice and support throughout their care.
Patients were often given the specialist nurse's phone
number as a point of contact if they had any concerns or
questions. This meant that contact with the specialist
nurse was easy, and could be patient-initiated, so patients
Table 3: Odds ratios for questions on patient experience of care: comparison of responses from patients who did, and did not, see a 
specialist nurse
Question Saw specialist nurse 
Frequency of positive 
responses/total responses (%)
Did not see specialist nurse 
Frequency of positive 
responses/total responses (%)
Age-adjusted odds ratio Odds 
ratio, (95% confidence interval) 
p value
1. Given enough written or printed 
information about the test results
175/225 (77.8) 14/32 (43.8) 4.58 (2.01; 10.43) p < 0.001
2. Given enough written or printed 
information about active treatment
163/195 (83.6) 14/25 (56.0) 3.73 (1.46; 9.56) p = 0.01
3. Given enough written or printed 
information about watchful waiting/
active monitoring
127/160 (79.4) 8/22 (36.4) 6.69 (2.45; 18.25) p < 0.001
4. Doctor or nurse clearly explained 
what treatment options would 
involve
210/239 (87.9) 22/36 (61.1) 3.51 (1.54; 8.01) p = 0.003
5. Doctor or nurse discussed clearly 
the possible side effects or 
consequences of treatment options
195/239 (81.6) 26/36 (72.2) 1.47 (0.63; 3.45) p = 0.37
6. Doctor or nurse gave an 
explanation of why the other 
treatment options were not suitable
136/202 (67.3) 15/30 (50) 2.05 (0.92; 4.60) p = 0.08
7. Doctor or nurse offered written 
or printed information about the 
treatment options
170/250 (68.0) 11/37 (29.7) 3.90 (1.76; 8.63) p = 0.001
8. Doctor or nurse offered written 
or printed information about the 
side effects or consequences of the 
treatment options
158/252 (62.7) 10/37 (27.0) 3.81 (1.71; 8.49) p = 0.001
9. Patient made decision about 
which type of treatment to have 
(alone or in partnership with a 
health professional)
157/251 (62.5) 11/37 (29.7) 2.69 (1.18; 6.12) p = 0.02
10. Doctor or nurse involved patient 
as much as wanted in the decision 
about which treatment to have
192/237 (81.0) 23/34 (67.6) 1.69 (0.73; 3.88) p = 0.22
11. After the treatment decision had 
been made, doctor or nurse told 
patient they could discuss their 
treatment decision again
152/235 (64.7) 10/34 (29.4) 3.78 (1.68; 8.53) p = 0.001
12. Doctor or nurse told patient 
that they could change their mind 
about which treatment to have
132/230 (57.4) 6/33 (18.2) 4.71 (1.82; 12.22) p = 0.001
13. Doctor or nurse gave patient 
enough information about sources of 
help (e.g. support group/charities)
226/252 (89.7) 16/37 (43.2) 9.36 (4.11; 21.34) p < 0.001BMC Health Services Research 2008, 8:65 http://www.biomedcentral.com/1472-6963/8/65
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could have access to support or information as and when
they needed it.
It worried me to death ...my mind were in like a whirl.
I felt, I had to ring... [specialist nurse], 'cause I ask, I
was asking myself questions I couldn't answer, you
know 'Why this? And why that?'...after I spoke to her I
felt a lot better ...Oh I can ring [specialist nurse] up any
time I want to (27)
Just having the contact number was seen as a source of
reassurance, whether or not the patient actually needed to
use it.
[You can] contact her any time you want to...That's
important that you can do that. What does it do, give
you sort of reassurance that if you've got a problem or
a concern that you can ring, that you know who to ring
(38)
Patients who did not have access to this relatively quick
and responsive source of support and information had to
wait until they had an opportunity, in a scheduled consul-
tation, to discuss issues of concern.
Interviewer: Would you find [contact number for spe-
cialist nurse] useful?
Patient: Yes, I would really because if um, odd times
I've passed a bit of blood from the bowel and I could
ring up and say, 'is that natural?'... You've sort of,
you've got to wait till the next appointment, which is
three months apart, and that's if they don't cancel it
again or nowt (31)
The ability of the specialist nurse to liaise between the medical 
system and the patient
The second unique aspect of the specialist nurse role was
that specialist nurses were seen as being in a position to
liaise between the medical system and the patient. This
involved firstly providing or restating information about
diagnosis and treatment in terms which were clearly
understandable to the patient, and secondly, acting as an
advocate for the patient to facilitate the care process.
Firstly, patients described specialist nurses as helping
them to understand and come to terms with their diagno-
sis and treatment through translating medical informa-
tion in order to present it in an understandable way. This
involved communicating in a patient-centred way and
using non-medical language. Specialist nurses were also
seen as more likely to address wider issues than simply the
diagnosis and treatment, such as the impact of treatments
on patients' lifestyles.
Patient: She did explain what the effects of the treat-
ments are, the hormone therapy and so on...
Wife: She was down to earth, she didn't come up with
any, you know so many medical terms...and she came
up with a lot of practical things that perhaps the con-
sultant wouldn't think to say... the fact that it's affect-
ing your lifestyle (48)
Secondly, patients described this liaison role in terms of
specialist nurses acting on their behalf to short-cut delays
in care, to gain more information for them, and even to
access particular medical services.
She can fiddle about and bang heads in the adminis-
tration and get things happening (48)
There is two specialist nurses there, I've got their num-
bers, I speak to them and if there's anything else they
will speak to the consultant and then they'll get back
to me (54)
I said 'I want... [test]'...My surgeon said ' [patient
name] does not require [test]'...But she got it, she got
it through another um, consultant (49)
Where specialist nurses were involved in patient support
groups, this helped to facilitate this informal liaison role.
When we go to our [patient support] meetings if I say
to the oncology nurse ... 'well I've been a little bit wor-
ried because...' so she says 'ok don't worry about it I'll
see Mr. so and so in the morning I'll give you a ring'
(1)
Discussion
Results from the questionnaire survey indicate that
patients who saw a specialist nurse were more likely to
have received written information and clear explanations
about their tests and treatment options, and about sources
of help and support. Patients who saw a specialist nurse
were more likely to say that they had made the treatment
decision themselves.
The qualitative findings elaborate on and help to explain
these differences. In interviews, patients described the
contribution of the specialist nurse to their experiences of
care immediately post-diagnosis, as well as over the
longer term of their treatment and monitoring for prostate
cancer. The specialist nurse was primarily seen as provid-
ing patients with time to talk and reflect on the diagnosis,
providing advice, information and support (including
information which could support the patient in making a
treatment decision), and in some cases helping to facili-
tate the course of the patient's care. When patients did notBMC Health Services Research 2008, 8:65 http://www.biomedcentral.com/1472-6963/8/65
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see a specialist nurse, they experienced gaps in their care,
in particular, a lack of time to talk things over post-diag-
nosis, and a lack of immediate access to advice and sup-
port over the course of their care.
Importantly, patients' accounts highlight the unique fea-
tures of the specialist nurse role, which make it possible
for specialist nurses to contribute to patients' positive
experiences of care. Firstly, patients described the availa-
bility of the specialist nurse, in terms of the amount of
time the specialist nurse was able to spend with them in
contrast with other medical staff such as consultants, and
the possibility of patient-initiated contact with the spe-
cialist nurse. This concurs with Boxhall and Dougherty's
study [15] in which patients valued the extra time availa-
ble to them with specialist nurses compared to doctors.
The second unique aspect of the specialist nurse role was
that specialist nurses were seen as being in a position to
liaise between the medical system and the patient. This
included providing or restating information about diag-
nosis and treatment in terms which were clearly under-
standable to the patient, and acting as an advocate for the
patient to facilitate the care process. These two key aspects
of care have been advocated as important to the specialist
nurse role [16], and this study indicates that these aspects
of the role are recognised and valued by patients
The unique nature of the specialist nurse role, with their
level of availability to the patient and their position at the
interface between the patient and the health system, was
seen as enabling specialist nurses to address specific
patient needs. Some of these needs could not be met by
professionals in different roles, as other roles do not share
the unique characteristics of the specialist nurse role (for
example, consultants are not able to offer patients their
time for unlimited periods). Taken together, the findings
of the questionnaire survey and the qualitative interviews
suggest that specialist nurses make a unique and valuable
contribution to patient experience of prostate cancer care.
There are several limitations to the work reported here
which should be noted. Firstly, the questionnaire survey
was not a randomised controlled study of an intervention,
and there is a risk of selection bias. It is possible that
patients who did and did not see a specialist nurse differed
on factors which were not measured as part of the study.
For example, patients who did not see a specialist nurse
may have felt less need for nurse input, or may have had
more or less advanced disease. This may have had an
impact on the study findings, given that only 12.8% of
participants had not seen a specialist nurse. However it is
notable that the groups did not differ in terms of treat-
ment type or health status. Those who did not see a spe-
cialist nurse were older than those who did, and it is
possible that some of the participants who did not see a
specialist nurse may have been given their diagnosis prior
to the widespread input of specialist nurses in care. The
survey involved a relatively small number of patients in
three hospitals, and responders to the survey were pre-
dominantly White British. In addition there were consid-
erable numbers of missing responses on some questions.
Although the response rate to the survey was relatively
high, the 40% of invited patients who did not respond to
the survey may differ systematically to those who did
respond, for example, they may be older, or have more
advanced disease. Hence the generalisability of the survey
results may be limited. The interviews reported here did
not systematically explore the role of the specialist nurse;
rather this was an issue raised spontaneously by patients,
and the analysis is limited to the issues raised by patients.
Also, the sampling frame for interviews did not aim spe-
cifically to sample those who did and did not see a special-
ist nurse. The studies do not make a distinction between
different types of specialist nurse (e.g. urology specialist
nurse and prostate cancer specialist nurse). Nevertheless,
the quantitative and qualitative components of the study
present complementary findings that together demon-
strate the benefits reported by patients of specialist nurses.
Conclusion
In conclusion, this study indicates that specialist nurses
play an important and unique role in prostate cancer care,
and have a positive impact on patient experience. It is
essential that specialist nurses are supported in their
unique role, and that their input is not threatened by
financial and organisational pressures.
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